Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hypertension 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1

Interventions

Nutrition Assessment 4Bevacizumab 3Lisinopril 2Labetalol 2Hydrochlorothiazide 2Angiotensin-Converting Enzyme Inhibitors 2ziprasidone 1pazopanib 1ganirelix 1enzalutamide 1clevidipine 1bicalutamide 1benazepril 1aliskiren 1Zolpidem 1Warfarin 1Vitamin D 1Vecuronium Bromide 1Vancomycin 1Urine Specimen Collection 1Tumor Necrosis Factors 1Tranexamic Acid 1Tobramycin 1Thiazides 1Therapeutics 1Surveys and Questionnaires 1Sunitinib 1Sulindac 1Standard of Care 1Spironolactone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypertension × Diltiazem × Clear all
NCT01408524 2014-04-01

Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and Diltiazem

Mahidol University

Phase 1/2 Completed
184 enrolled

Hypertension

Data powered by HemOnc (CC BY 4.0) Colophon âš¡